KLK15 is a new potential independent marker for unfavorable prognosis in ovarian cancer.

被引：0
|
作者：
Yousef, GM
Scorilas, A
Fracchioli, S
Iskander, L
Raouf, AA
Massobrio, M
Katsaros, D
Diamandis, EP
机构：
[1] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
[2] Natl Ctr Sci Res, Athens, Greece
[3] Univ Turin, Turin, Italy
[4] Univ Toronto, Toronto, ON, Canada
[5] Menoufia Univ, Shibin Al Kawm, Egypt
来源：
CLINICAL CHEMISTRY | 2002年 / 48卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
D118
引用
收藏
页码：A148 / A148
页数：1
相关论文
共 50 条
  • [1] The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer
    G M Yousef
    A Scorilas
    A Magklara
    N Memari
    R Ponzone
    P Sismondi
    N Biglia
    M Abd Ellatif
    E P Diamandis
    British Journal of Cancer, 2002, 87 : 1294 - 1300
  • [2] The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer
    Yousef, GM
    Scorilas, A
    Magklara, A
    Memari, N
    Ponzone, R
    Sismondi, P
    Biglia, N
    Abd Ellatif, M
    Diamandis, EP
    BRITISH JOURNAL OF CANCER, 2002, 87 (11) : 1294 - 1300
  • [3] KLK15 is a prognostic marker for progression-free survival in patients with radical prostatectomy
    Rabien, Anja
    Fritzsche, Florian R.
    Jung, Monika
    Toelle, Angelika
    Diamandis, Eleftherios P.
    Miller, Kurt
    Jung, Klaus
    Kristiansen, Glen
    Stephan, Carsten
    INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (10) : 2386 - 2394
  • [4] Kallikrein 15 (KLK15) in prostate cancer:: in silico analysis and single nucleotide polymorphism verification
    Kedda, M. A.
    Skeie, L. M.
    Smith, R. L. G.
    Higgins, M.
    Spurdle, A. B.
    Yaxley, J.
    Steginga, S.
    Clements, J. A.
    BJU INTERNATIONAL, 2006, 97 : 5 - 5
  • [5] A Kallikrein 15 (KLK15) single nucleotide polymorphism located close to a novel exon shows evidence of association with poor ovarian cancer survival
    Batra, Jyotsna
    Nagle, Christina M.
    O'Mara, Tracy
    Higgins, Melanie
    Dong, Ying
    Tan, Olivia L.
    Lose, Felicity
    Skeie, Lene Marie
    Srinivasan, Srilakshmi
    Bolton, Kelly L.
    Song, Honglin
    Ramus, Susan J.
    Gayther, Simon A.
    Pharoah, Paul D. P.
    Kedda, Mary-Anne
    Spurdle, Amanda B.
    Clements, Judith A.
    BMC CANCER, 2011, 11
  • [6] Molecular cloning of the human kallikrein 15 gene (KLK15) -: Up-regulation in prostate cancer
    Yousef, GM
    Scorilas, A
    Jung, K
    Ashworth, LK
    Diamandis, EP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (01) : 53 - 61
  • [7] The serum hyaluronan is a potential marker for epithelial ovarian cancer.
    Anttila, M
    Hiltunen, E
    Tammi, R
    Heinonen, S
    Yliskoski, M
    Juhola, M
    Kosma, VM
    Tammi, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 470S - 470S
  • [8] A Kallikrein 15 (KLK15) single nucleotide polymorphism located close to a novel exon shows evidence of association with poor ovarian cancer survival
    Jyotsna Batra
    Christina M Nagle
    Tracy O'Mara
    Melanie Higgins
    Ying Dong
    Olivia L Tan
    Felicity Lose
    Lene Marie Skeie
    Srilakshmi Srinivasan
    Kelly L Bolton
    Honglin Song
    Susan J Ramus
    Simon A Gayther
    Paul DP Pharoah
    Mary-Anne Kedda
    Amanda B Spurdle
    Judith A Clements
    BMC Cancer, 11
  • [9] Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer:: A new independent and favorable prognostic marker
    Yousef, GM
    Kyriakopoulou, LG
    Scorilas, A
    Fracchioli, S
    Ghiringhello, B
    Zarghooni, M
    Chang, A
    Diamandis, M
    Giardina, G
    Hartwick, WJ
    Richiardi, G
    Massobrio, M
    Diamandis, EP
    Katsaros, D
    CANCER RESEARCH, 2001, 61 (21) : 7811 - 7818
  • [10] Expression analysis and study of the KLK15 mRNA splice variants in prostate cancer and benign prostatic hyperplasia
    Mavridis, Konstantinos
    Avgeris, Margaritis
    Koutalellis, Georgios
    Stravodimos, Konstantinos
    Scorilas, Andreas
    CANCER SCIENCE, 2010, 101 (03): : 693 - 699
12345